Isolation and characterization of a transfectant influenza B virus altered in RNA segment 6

References

1. Air G. M., Laver W. G., Luo M., Stray S. J., Legrone G., Webster R. G. 1990; Antigenic sequence, and crystal variation in influenza B neuraminidase. Virology 177:578–587
   [Google Scholar]
2. Barclay W. S., Palese P. 1995; Influenza B viruses with site-specific mutations introduced into the HA gene. Journal of Virology 69:1275–1279
   [Google Scholar]
3. Betakova T., Nermut M. V., Hay A. J. 1996; The NB protein is an integral component of the membrane of influenza B virus. Journal of General Virology 77:2689–2694
   [Google Scholar]
4. Bilsel P., Castrucci M. R., Kawaoka Y. 1993; Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions. Journal of Virology 67:6762–6767
   [Google Scholar]
5. Blick T. J., Tiong T., Sahasrabudhe A., Varghese J. N., Colman P. M., Hart G. J., Bethell R. C., McKimm-Breschkin J. L. 1995; Generation and characterisation of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase specific inhibitor 4-guanadino-Neu5Ac2en. Virology 214:475–484
   [Google Scholar]
6. Blick T. J., Sahasrabudhe A., McDonald M., Owens I. J., Morley P. J., Fenton R. J., McKimm-Breschkin J. L. 1998; The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-Guanidino-Neu5Ac2en. Virology 246:95–103
   [Google Scholar]
7. Brassard D. L., Leser G. P., Lamb R. A. 1996; Influenza B virus NB glycoprotein is a component of virions. Virology 220:350–360
   [Google Scholar]
8. Burmeister W. P., Ruigrock R. W. H., Cusack S. 1992; The 2·2 Å resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO Journal 11:49–56
   [Google Scholar]
9. Burmeister W. P., Baudin F., Cusack S., Ruigrok R. W. H. 1993; Comparison of structure and sequence of influenza B/Yamagata and B/Beijing neuraminidase shows a conserved head but much greater variability in the stalk and NB protein. Virology 192:683–686
   [Google Scholar]
10. Castrucci M. R., Kawaoka Y. 1993; Biologic importance of stalk length in influenza A virus. Journal of Virology 67:759–764
    [Google Scholar]
11. Chizmakov I., Ogden D., Betakova T., Phillips A., Hay A. 1998; Cl− and H+ permeability formed by expression of NB protein from influenza B virus. Biophysical Journal 74:A319
    [Google Scholar]
12. Colacino J. M., Chirgadze N. Y., Garman E., Murit G., Loncharich R. J., Baxter A. J., Staschke K. A., Laver W. G. 1997; A single sequence change destabilizes the influenza virus neuraminidase. Virology 236:66–75
    [Google Scholar]
13. Coleman P. M. 1989; Neuraminidase: enzyme and antigen. In The Influenza Viruses pp 175–210 Edited by Krug R. M. New York: Plenum Press;
    [Google Scholar]
14. Egorov A., Brandt S., Sereinig S., Romanova J., Ferko B., Katinger D., Grassauer A., Alexandrova G., Katinger H., Muster T. 1998; Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. Journal of Virology 72:6437–6441
    [Google Scholar]
15. Enami M., Palese P. 1991; High efficiency formation of influenza virus transfectants. Journal of Virology 65:2711–2731
    [Google Scholar]
16. Enami M., Luytjes W., Krystal M., Palese P. 1990; Introduction of site-specific mutations into the genome of influenza virus. Proceedings of the National Academy of Sciences USA 87:3802–3805
    [Google Scholar]
17. Grassauer A., Egorov A. Y., Ferko B., Romanova I., Katinger H., Muster T. 1998; A host restriction-based selection system for influenza haemagglutinin transfectant viruses. Journal of General Virology 79:1405–1409
    [Google Scholar]
18. Gubareva L. V., Bethell R., Hart G. J., Murti K. G., Penn C. R., Webster R. G. 1996; Characterisation of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanadino-Neu5Ac2en. Journal of Virology 70:1818–1827
    [Google Scholar]
19. Gubareva L. V., Matrosovich M. N., Brenner M. K., Bethell R. C., Webster R. G. 1998; Evidence for zanamavir resistance in an immunocompromised child infected with influenza B virus. Journal of Infectious Diseases 178:1257–1262
    [Google Scholar]
20. Horimoto T., Kawaoka Y. 1994; Reverse genetics provides direct evidence for a correlation of haemagglutinin cleavability and virulence of an avian influenza A virus. Journal of Virology 68:3120–3128
    [Google Scholar]
21. Lamb R. A., Krug R. M. 1996; Orthomyxoviridae : the viruses and their replication. In Fields Virology pp 1353–1396 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
22. Li S. Q., Schulman J. L., Moran T., Bona C., Palese P. 1992; Influenza A virus transfectants with chimaeric haemagglutinins containing epitopes from different subtypes. Journal of Virology 66:399–404
    [Google Scholar]
23. Li S. Q., Schulman J., Itamura S., Palese P. 1993; Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. Journal of Virology 67:6667–6673
    [Google Scholar]
24. Li S. Q., Xu M. L., Coelingh K. 1995; Electroporation of influenza virus ribonucleoprotein complexes for the rescue of nucleoprotein and matrix genes. Virus Research 37:153–161
    [Google Scholar]
25. Luo G. X., Bergmann M., Garcia-Sastre A., Palese P. 1992; Mechanism of attenuation of a chimaeric influenza A/B transfectant virus. Journal of Virology 66:4670–4685
    [Google Scholar]
26. Luo G. X., Chung J., Palese P. 1993; Alterations of the stalk of the influenza virus neuraminidase – deletions and insertions. Virus Research 29:141–153
    [Google Scholar]
27. McKimm-Breschkin J. L., McDonald M., Blick T. J., Colman P. M. 1996; Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanadino-Neu5Ac2en leads to instability of the enzyme. Virology 225:240–242
    [Google Scholar]
28. McKimm-Breschkin J. L., Sahasrabudhe A., Blick T. J., McDonald M., Colman P. M., Hart G. J., Bethell R. C., Varghese J. N. 1998; Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. Journal of Virology 72:2456–2462
    [Google Scholar]
29. Muster T., Subbarao E. K., Enaimi M., Murphy B. R., Palese P. 1991; An influenza A virus containing influenza B virus 5′ and 3′ non-coding regions on the neuraminidase gene is attenuated in mice. Proceedings of the National Academy of Sciences USA 88:5177–5181
    [Google Scholar]
30. Palese P., Tobita K., Ueda M., Compans R. W. 1974; Characterisation of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397–410
    [Google Scholar]
31. Percy N., Barclay W. S., Garcia-Sastre A., Palese P. 1994; Expression of a foreign protein by influenza A virus. Journal of Virology 68:4486–4492
    [Google Scholar]
32. Potier M., Mameli L., Belisle M., Dallaire L., Melancon S. B. 1979; Fluorimetric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d- N -acetylneurminate) substrate. Analytical Biochemistry 94:287–296
    [Google Scholar]
33. Shibata S., Yamamoto-Goshima F., Maeno K., Hanaichi T., Fukjita Y., Nakajima K., Imai M., Komatsu T., Sugiura S. 1993; Characterisation of a temperature-sensitive influenza B virus mutant defective in neuraminidase. Journal of Virology 67:3264–3273
    [Google Scholar]
34. Staschke K. A., Coalcino J. M., Baxter A. J., Air G. M., Bansal A., Hornback W. J., Monroe J. E., Laever W. G. 1995; Molecular basis for the resistance of influenza viruses to 4-Guanidino-Neu5Ac2en. Virology 214:642–646
    [Google Scholar]
35. Stevens M., Barclay W. S. 1998; The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA. Journal of Virology 72:5307–5312
    [Google Scholar]
36. Subbarao E. K., Kawaoka Y., Murphy B. R. 1993; Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation. Journal of Virology 678:7223–7228
    [Google Scholar]
37. Sunstrom N. A., Premkumar L. S., Premkumar A., Ewart G., Cox G. B., Gage P. W. 1996; Ion channels formed by NB, an influenza B virus protein. Journal of Membrane Biology 150:127–132
    [Google Scholar]
38. Tai C. Y., Escarpe P. A., Sidwell R. W., Williams M. A., Lew W., Wu H., Kim C. U., Mendell D. B. 1998; Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS4071. Antimicrobial Agents and Chemotherapy 42:3234–3241
    [Google Scholar]
39. Von Itzstein M., Wu W. Y., Kok G. B., Pegg M. S., Dyason J. C., Jin B., Phan T. V., Smythe M. L., White H. F., Oliver S. W., Colman P. M., Varghese J. N., Ryan D. M., Woods J. M., Bethell R. C., Hotham V. J., Cameron J. M., Penn C. R. 1993; Rational design of potent sialidase-based inhibitors of influenza-virus replication. Nature 363:418–423
    [Google Scholar]
40. Ward T., Pipkin P. A., Clarkson N. A., Stone D. M., Minor P. D., Almond J. W. 1994; Decay accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immune-focal cloning method. EMBO Journal 13:5070–5074
    [Google Scholar]
41. Yamamoto-Goshima F., Maeno K., Morishita T., Ueda M., Fujita Y., Nakajima K., Yoshi S. 1994; Role of neuraminidase in the morphogenesis of influenza B virus. Journal of Virology 68:1250–1254
    [Google Scholar]
42. Zheng H. Y., Paelese P., Garcia-Sastre A. 1996; Nonconserved nucleotides at the 3′-end and 5′-end of an influenza A virus RNA play an important role in viral RNA replication. Virology 217:242–251
    [Google Scholar]